Press release
Market Survey : Global Parkinsons Disease Market Professional Survey Report 2018 Teva, Novartis, GSK, AbbVie, Merck, Impax, Lundbeck,UCB,
This report studies the global Parkinson's Disease market status and forecast, categorizes the global Parkinson's Disease market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).
The global Parkinson's Disease market is valued at 4240 million US$ in 2017 and will reach 6810 million US$ by the end of 2025, growing at a CAGR of 6.1% during 2018-2025.
The major manufacturers covered in this report
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Valeant Pharmaceuticals
Acadia
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1862362
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
By Application, the market can be split into
Hospitals
Clinics
The study objectives of this report are:
To analyze and study the global Parkinson's Disease capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Parkinson's Disease manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Parkinson's Disease are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Parkinson's Disease Manufacturers
Parkinson's Disease Distributors/Traders/Wholesalers
Parkinson's Disease Subcomponent Manufacturers
Industry Association
Downstream Vendors
Table of Contents
Global Parkinson's Disease Market Professional Survey Report 2018
1 Industry Overview of Parkinson's Disease
1.1 Definition and Specifications of Parkinson's Disease
1.1.1 Definition of Parkinson's Disease
1.1.2 Specifications of Parkinson's Disease
1.2 Classification of Parkinson's Disease
1.2.1 Carbidopa/Levodopa
1.2.2 Dopamine Receptor Agonists
1.2.3 MAO-Inhibitors
1.3 Applications of Parkinson's Disease
1.3.1 Hospitals
1.3.2 Clinics
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-parkinsons-disease-market-professional-survey-report-2018-report.html/toc
2 Manufacturing Cost Structure Analysis of Parkinson's Disease
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Parkinson's Disease
2.3 Manufacturing Process Analysis of Parkinson's Disease
2.4 Industry Chain Structure of Parkinson's Disease
3 Technical Data and Manufacturing Plants Analysis of Parkinson's Disease
3.1 Capacity and Commercial Production Date of Global Parkinson's Disease Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Parkinson's Disease Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Parkinson's Disease Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Parkinson's Disease Major Manufacturers in 2017
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Market Survey : Global Parkinsons Disease Market Professional Survey Report 2018 Teva, Novartis, GSK, AbbVie, Merck, Impax, Lundbeck,UCB, here
News-ID: 1141962 • Views: …
More Releases from Parkinsons Disease Market
Growth of Parkinsons Disease Market in Global Industry : Overview, Size and Shar …
Albany, NY, 20th September : Recent research and the current scenario as well as future market potential of "Global Parkinsons Disease Market Report: 2016 Edition" globally.
Parkinsons Disease (PD) is a chronic and progressive neurodegenerative or movement disorder which involves the malfunction and death of vital nerve cells in the brain, called neurons. Parkinsons primarily affects neurons in an area of the brain called the “substantia nigra”. The early signs and…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
